Skip to main content

Table 2 Results of modified Delphi panel (round 3)

From: A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care

KPIMedian (range) of 10 panel participants
ImportanceFeasibilityPriority
Indicator 1: Assessment of arthritis-related pain8 (6–9)8 (6–9)8 (8–9)
Indicator 2: Rheumatological joint count9 (7–9)8 (7–9)9 (8–9)
Indicator 3: Physician’s global assessment of disease activity8 (6–9)7.5 (6–8)8 (7–9)
Indicator 4: Assessment of functional ability7 (5–9)7 (3–8)7 (6–9)
Indicator 5: Assessment of functional ability using the CHAQ7 (3–9)5.5 (2–8)7 (4–9)
Indicator 6: Composite disease activity measurement8 (6–9)7 (5–8)8 (6–9)
Indicator 7: Tuberculosis screening8 (5–9)8 (7–9)8 (5–9)
Indicator 8: Laboratory monitoring for DMARDs8 (6–9)8 (7–9)8 (7–9)
Indicator 9: Waiting times for rheumatologist consultation for patients with new onset JIA8 (6–9)7 (4–8)8 (5–9)
Indicator 10: Percentage of patients with JIA seen by a rheumatologist7.5 (6–9)7 (1–9)7 (4–9)
Indicator 11: Percentage of patients seen in yearly follow-up by a pediatric rheumatologist7 (4–8)8 (5–9)7 (5–8)
Indicator 12: Median time from the patient’s first clinic visit to the date of their first uveitis screening8 (6–9)6 (2–9)8 (3–9)
Indicator 13: Assessment of health-related quality of life7 (4–8)6 (2–8)7 (5–8)
Indicator 14: Assessment of patients/parent satisfaction with care7 (3–8)5 (2–7)7 (3–7)
  1. KPI key performance indicator, CHAQ The Childhood Health Assessment Questionnaire, DMARDs disease-modifying anti-rheumatic drugs. Only KPIs with median scores of ≥ 7 on all 3 questions with no disagreement were included in the final set. Ratings 4–6 were categorized as “uncertain”
\